Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

View all journals
Search
Log in

nature
search

Search

Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

Nature Medicine (3)
Scientific Reports (3)
Nature Communications (1)
npj Precision Oncology (1)

Choose more journals

Article type Check one or more article types to show results from those article types only.

Research (5)
Amendments and Corrections (2)
Reviews (1)

Subject Check one or more subjects to show results from those subjects only.

Biochemistry
Cancer
Chemistry
Diseases
Medical research
Molecular medicine
Oncology
Physics

Date Choose a date option to show results from those dates only.

Today
Last 7 days
Last 30 days
Last 12 months
Last 2 years
Last 5 years

Custom date range

Clear all filters

Sort by:

Relevance

Date published (new to old)

Date published (old to new)

Showing 1–8 of 8 results

Advanced filters: Author: Andrea Gottardo Clear advanced filters

Author Correction: The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial

Lindsay B. Kilburn
Dong-Anh Khuong-Quang
Karsten Nysom
Amendments and CorrectionsOpen Access16 Apr 2025
Nature Medicine

Volume: 31, P: 2454
Search for ²²Na in novae supported by a novel method for measuring femtosecond nuclear lifetimes

The authors report a particle-particle correlation and velocity-difference profile method to measure nuclear lifetime. The results obtained for excited states of 23Mg are used to constrain the production of 22Na in the astrophysical novae explosions.

Chloé Fougères
François de Oliveira Santos
Magdalena Zielińska
ResearchOpen Access05 Sept 2023
Nature Communications

Volume: 14, P: 1-7
Clarifying the radiative decay of the Hoyle state with charged-particle spectroscopy

D. Dell’Aquila
I. Lombardo
N. Vukman
ResearchOpen Access15 Aug 2024
Scientific Reports

Volume: 14, P: 1-6
The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial

In a phase 2 trial, the oral type II RAF inhibitor tovorafenib exhibited an overall response rate of 67% in patients with BRAF-altered relapsed/refractory pediatric low-grade glioma.

Lindsay B. Kilburn
Dong-Anh Khuong-Quang
Karsten Nysom
ResearchOpen Access17 Nov 2023
Nature Medicine

Volume: 30, P: 207-217
Author Correction: The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial

Lindsay B. Kilburn
Dong-Anh Khuong-Quang
Karsten Nysom
Amendments and CorrectionsOpen Access11 Mar 2024
Nature Medicine

Volume: 30, P: 1500
Clinical utility of ctDNA by amplicon based next generation sequencing in first line non small cell lung cancer patients

Valerio Gristina
Tancredi Didier Bazan Russo
Antonio Galvano
ResearchOpen Access27 Sept 2024
Scientific Reports

Volume: 14, P: 1-9
Ambient mass spectrometry for rapid authentication of milk from Alpine or lowland forage

Alessandra Tata
Andrea Massaro
Severino Segato
ResearchOpen Access05 May 2022
Scientific Reports

Volume: 12, P: 1-11
The intersection of homologous recombination (HR) and mismatch repair (MMR) pathways in DNA repair-defective tumors

Lorena Incorvaia
Tancredi Didier Bazan Russo
Viviana Bazan
ReviewsOpen Access05 Sept 2024
npj Precision Oncology

Volume: 8, P: 1-12